Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism A2bR antagonists(Adenosine A2b receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis | IND Application | IN | 30 Jan 2022 | |
Colitis, Ulcerative | Preclinical | IN | 07 Sep 2022 | |
Colorectal Cancer | Preclinical | - | - |